The parallel medicinal chemistry (PMC) was effectively applied to accelerate the optimization of diacylglycerol O-acyltransferase I (DGAT-1) inhibitors. Through a highly collaborative and iterative library design, synthesis and testing, a benzimidazole lead was rapidly and systematically advanced to a highly potent, selective and bioavailable DGAT1 inhibitor with the potential for further development.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmcl.2019.03.039 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!